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Abstract:  
 
Levels and causes of mortality in mothers and babies are intrinsically linked, occurring 
around the same time and often to the same mother-baby dyad, though mortality rates are 
substantially higher in babies. Measuring levels, trends and causes of maternal, neonatal 
and fetal mortality are important for understanding priority areas for interventions and 
tracking the success of interventions at the global, national, regional and local level. 
However, there are many measurement challenges.  
 
This paper provides an overview of the definitions and indicators for measuring mortality in 
pregnant and postpartum women (maternal and pregnancy-related mortality) and their 
babies (fetal and neonatal mortality). We then discuss current issues in the measurement of 
the levels and causes of maternal, fetal and neonatal mortality, and present options for 
improving measurement of these outcomes. Finally, we illustrate some important uses of 
mortality data, including for the development of models to estimate mortality rates at the 
global and national level and for audits.  
 
Key words: Stillbirth, fetal, neonatal, maternal, mortality measurement, cause-of-death 
measurement, indicators, data sources 
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Introduction 
 
Monitoring levels of maternal mortality has been a priority on the global health agenda. 
Millennium Development Goal (MDG) 5 aimed to reduce the maternal mortality ratio (MMR) 
by 75% between 1990 and 2015. However, measuring progress over this time-period was 
challenging, primarily because of the scarcity of empirical data. Global tracking relied instead 
on modelled estimates to monitor the success.(1) These suggested that maternal mortality 
decreased by 44% worldwide.(2) Similar challenges were faced in tracking fetal and 
neonatal mortality. Neonatal deaths were not explicitly mentioned in MDG 4, which sought to 
reduce under-5 child mortality by two thirds, but they were increasingly recognized as 
comprising almost half, of child mortality globally and progressing more slowly. Neonatal 
mortality was estimated to have decreased by 47% worldwide.(3) Stillbirths (late fetal 
deaths) were excluded from the MDG targets, and consequently received less attention, 
although the major associated burden has been quantified more recently.(4) At the end of 
the MDG era, the number of deaths, albeit based on modelled estimates, remains 
unacceptably high: 303,000 maternal deaths(2), 2.6 million stillbirths (late fetal deaths)(5) 
and 2.7 million neonatal deaths.(3)   
 
Measuring the levels and trends of maternal, neonatal, and fetal mortality is important for 
quantifying disease burden, understanding risk factors and determinants, identifying priority 
areas for interventions, programmes and policies, and evaluating the success of 
interventions at the global, national, regional, and local level.(6, 7) Knowing the biomedical 
causes of mortality in pregnant or recently-delivered women, or in their babies, is essential to 
direct interventions to prevent such deaths. Unfortunately, there are many challenges to 
measurement, but there are also numerous potential options and solutions.  
 
This paper provides an overview of current issues and options in measuring the levels and 
causes of maternal, fetal, and neonatal mortality. We define the deaths and indicators, and 
then focus on the measurement methods, challenges and solutions, and where possible, 
present potential opportunities to improve measurement of maternal, neonatal and fetal 
death.  
 
Definitions 
 
To compare maternal, fetal, and neonatal mortality across populations or over time requires 
standardised definitions for each outcome. These were included in 10th revision of the 
International Classification of Diseases (ICD-10),(8) as summarised in Table 1 and 
described below. Various dimensions of these definitions require an ability to assess 
pregnancy status of women, the timing of death in relation to delivery, gestational age (or 
alternatively birth weight or birth length) at delivery, vital status at the start of labour and at 
birth and cause-of-death. The dimensions and critical time periods are shown schematically 
in Figure 1. 
  
Maternal and pregnancy-related mortality 
 
“Maternal death”, is defined in the ICD-10(8) as “the death of a woman while pregnant or 
within 42 days of termination of pregnancy, irrespective of the duration and site of the 
pregnancy, from any cause related to or aggravated by the pregnancy or its management, 
but not from accidental or incidental causes” (Table 1). This definition encompasses direct 
obstetric deaths, when death occurs because of an obstetric complication such as 
haemorrhage or eclampsia, and indirect obstetric deaths, when an underlying, previously-
existing medical condition, or non-obstetric medical condition which developed during 
pregnancy, is aggravated by pregnancy. Since deaths that are accidental or incidental to the 
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pregnancy need to be excluded, information on cause-of-death is required to apply this 
definition.   
 
However, the definition of maternal death is conceptually problematic from a measurement 
perspective.(9) Distinguishing indirect maternal death from incidental or accidental deaths 
during pregnancy or the postpartum is epidemiologically challenging, and consequently 
coding can be difficult. The decision whether a condition is aggravated by pregnancy or its 
management can either be made on a case-by-case basis, be ascribed to conditions based 
on epidemiologic data showing elevated incidence or case-fatality in pregnant women with 
the condition compared to non-pregnant women, or be decided for entire classes of 
conditions (e.g. deaths from external causes). Guidance is provided but is not particularly 
helpful; for example, ICD-MM instructs that HIV-related deaths should be classified as 
maternal when “there is an aggravating effect of pregnancy on HIV and the interaction 
between pregnancy and HIV is the underlying cause-of-death”.(10) It further states that if 
“the woman’s pregnancy status is incidental to the course of her HIV infection” then the 
death should not be classified as maternal. Unfortunately, ICD-MM provides no guidance on 
how to identify when HIV disease progression has been accelerated by pregnancy, making 
the coding of these deaths very difficult, particularly in the absence of detailed data. 
Furthermore, epidemiological studies suggest that certain causes of death that are often 
excluded from maternal mortality estimates, such as suicide or homicide, are more likely to 
occur in certain sub-sets of pregnant women compared to non-pregnant women (notably 
amongst younger age groups).(11)  
 
While maternal death is the most widely used mortality definition in pregnant and postpartum 
women, the ICD-10 gives two further definitions that expand the deaths captured in two 
different ways. First, “late maternal death” lengthens the time-period, to capture maternal 
deaths occurring from 42 days up to one year postpartum. The 42-day postpartum cut-off 
has a weak evidence-base, and a few studies show women remain at elevated risk for 
several months after delivery.(12) Historically, a 90-day cut-off has been used,(13, 14) and 
some even argue that the increased mortality risk may extend beyond one year 
postpartum.(15) Second, “pregnancy-related death” includes any “death of a woman while 
pregnant or within 42 days of termination of pregnancy, irrespective of the cause-of-death”, 
without excluding accidental or incidental deaths in this specified time-period. This latter 
definition only requires information on the timing of death in relation to pregnancy (or the end 
of pregnancy), and not on the cause-of-death (Figure 1). As such, pregnancy-related death 
is comparable to neonatal and fetal deaths that are also defined primarily by time-periods, as 
described below. 
 
Fetal and neonatal mortality 
 
Livebirth is defined in ICD-10(8) as “the expulsion or extraction from its mother of a product 
of human conception, irrespective of the duration of the pregnancy, which, after such 
expulsion or extraction, breathes or shows any other evidence of life such as beating of the 
heart, pulsation of the umbilical cord, or definite movement of voluntary muscles, whether or 
not the umbilical cord has been cut or the placenta is attached. Heartbeats are to be 
distinguished from transient cardiac contractions; respirations are to be distinguished from 
fleeting respiratory efforts or gasps.” The ICD-10(8) definition for neonatal death is the death 
of a live born infant in the first 28 days of life; this definition is applied nearly universally 
(Table 1 and Figure 1).  
 
Fetal death is “death prior to the complete expulsion or extraction from its mother of a 
product of human conception, irrespective of the duration of pregnancy and which is not an 
induced termination of pregnancy.” Death is indicated by the fetus not showing signs of 
being a livebirth, as described above. ICD-10 defines fetal deaths as occurring from ≥500 
grams, or ≥22 weeks, or >25cms only. Deaths before this period are spontaneous abortions, 
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or miscarriages in lay terminology. Definitions and terminology for fetal deaths are applied 
more inconsistently -- especially amongst high-income countries with thresholds ranging 
from 20 weeks gestational age upwards (Figure 1).(16, 17) ICD-10 distinguishes early from 
late fetal deaths using birthweight, gestational age, or length criteria. ICD-10 recommends 
reporting both early and late fetal mortality rates, while WHO recommends using the stillbirth 
rate or late fetal death rate for international comparisons. The term ‘stillbirth’ is often used in 
clinical practice and common parlance to refer to any fetal death; however, it is used 
epidemiologically and in global estimates to refer to late fetal deaths only. 
 
Since ICD-10 was developed several decades ago the fetal death threshold was set to be 
based first on birthweight criterion then gestational age and then length. However, 
birthweight and gestational age thresholds do not give equivalent results. For example in the 
USA the SBR would be 40% lower than with a 500gm threshold compared to a 22 weeks 
gestation threshold. Hence the threshold should be based on one parameter as it is not 
accurate to assume equivalence.  In practice, most health facilities could measure 
birthweight at the time of delivery, yet in reality less than half of the world’s births are 
weighed and fewer stillbirths are weighed.  Gestational age can be difficult to assess without 
records from early ultrasound as the gold standard or dating based on last menstrual 
period.(18-20). Nevertheless, we would argue that assessment of gestational age is 
essential to enable correct classification of a fetal death to the early or late category to allow 
for international comparisons. This is used in practice in middle and high income countries, 
and increasingly in low income settings. It is proposed that the 11th ICD revision change to a 
gestational-age based fetal death threshold, in line with most high-income country reporting.  
 
Assessing the intrapartum versus antepartum timing of fetal death is another area where 
definitions may be applied differently in different settings with lower level care. If evidence of 
a fetal heartbeat at the start of labour is not available, classification as intrapartum or 
antepartum often relies on an assessment of the skin of the baby (fresh versus macerated), 
which is not a very reliable indicator of ante or intra-partum timing of fetal death.(21, 22) 
 
Indicators 
 
Counting numbers of maternal, fetal, and neonatal deaths can identify countries, regions or 
sub-groups with the largest numeric burden, but often we are also interested in knowing 
where the risk of such deaths is highest. For example, due to its large population, India has 
a much greater number of maternal deaths compared to Sierra Leone, yet the risk of a 
woman in India dying of maternal causes is much lower than in Sierra Leone.(2) Identifying 
the risk faced by individual women or babies requires the numbers of deaths be considered 
in relation to a denominator at risk of these deaths. Below we describe commonly used 
indicators of risk, as well as others used in mortality measurement.  
 
Maternal indicators 
 
Assessing the risk of maternal or pregnancy-related mortality requires relating the number of 
such deaths in a given time-period and a given country or area, to the number of women at 
risk. The ideal denominator for this – the number of pregnant woman entering into the 
pregnancy/postpartum period, or time spent pregnant or postpartum – is difficult to obtain 
without conducting prospective studies of large groups of women. Instead, routine data 
sources are commonly used to calculate a maternal mortality ratio: the number of maternal 
deaths per 100,000 livebirths in a given time period: (number of deaths/livebirths) X 100,000. 
This livebirth denominator approximates the number of pregnancies, but excludes women 
who have miscarriages, induced abortions or stillbirths, while women having multiple 
livebirths (e.g. twins or triplets) are counted multiple times in the denominator. In some 
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settings, all maternity cases, including those resulting in fetal deaths, and even induced 
abortions, are included in the denominator.(23)  
 
Three additional, less commonly reported, indicators are defined below: 
 
1. Maternal (or pregnancy-related) mortality rate: deaths per 100,000 women aged 15-
49 per year (mid-point population) 
2. Lifetime risk of maternal (or pregnancy-related) death: the probability that a 15-year-
old female will die eventually from maternal (or pregnancy-related) causes, assuming 
that current levels of fertility and mortality (including maternal (or pregnancy-related)  
mortality) do not change in the future, and taking into account competing causes of 
death.(24)   
3. Proportion of deaths: proportion of maternal (or pregnancy-related) deaths among all 
deaths of women of reproductive age. 
 
The maternal (or pregnancy-related) mortality ratio and the level of fertility influence all three 
indicators. For any given maternal mortality ratio, the higher the level of fertility, the higher 
the level of the three indicators. The lifetime risk indicator and the proportion of deaths are 
also influenced by death rates among non-pregnant/non-postpartum women: all else being 
equal, the higher the death rates in non-pregnant/non-postpartum women, the lower these 
two indicators will be.  
 
Fetal and neonatal indicators 
 
Mortality indicators for outcomes in babies are usually measured per 1,000 births. Neonatal 
mortality rates use livebirths as the denominator: (number of neonatal deaths)/(livebirths) X 
1,000. Fetal mortality rates are: (number fetal deaths)/(livebirths + fetal deaths) X 1,000. A 
combined indicator for all ‘perinatal deaths’,(8) is used that includes all late fetal deaths 
(≥1,000g or ≥28 weeks) and all early neonatal deaths (days 0 – 6): (number perinatal 
deaths)/(livebirths + fetal deaths) X 1,000. 
 
It is recommended that all deaths in babies less than 28 days of age, whether in-utero above 
a specified threshold, or in the neonatal period, are recorded by gestational age, birthweight 
and timing (ante- or intra-partum, and day of neonatal death). Such reporting of outcomes is 
of programmatic relevance. For example, the ‘Intrapartum Stillbirth and Early Neonatal 
Death Indicator’, may be used to monitor improvements of the quality of obstetric and 
newborn care provided at birth. It can be calculated at a facility level as: (intrapartum 
stillbirths + neonatal deaths within the first 24 hours of life (≥2,500g))/(livebirths+ fetal deaths 
(≥2,500 grams)).(25, 26)  
 
Another, less frequently used, measure is the ‘prospective fetal mortality rate’: (number of 
fetal deaths at a gestational age per 1,000 fetal deaths at that gestational age or greater, 
plus livebirths). This is a more accurate denominator for those at risk, and provides an 
estimate of the risk of fetal death at a given gestational age.(27, 28) In high-income settings, 
this indicator has been used to compare the risk of fetal death with the neonatal mortality 
rate to determine the optimal gestational age for delivery.(29)  
 
Current issues in measuring mortality 
 
Despite the existence of definitions and indicators, measuring mortality can be problematic. 
First, deaths need to be identified, and then categorized and counted. Deaths may be 
misclassified because aspects of their definitions (including pregnancy/postpartum status, 
incidental/accidental cause-of death, gestational age, survival status at start of labour and at 
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delivery, and day of death postpartum) are difficult to recognize, determine, capture, or 
remember.  They can also be misclassified because information is deliberately misreported 
for reasons related to blame or stigma or to protect women or avoid bureaucracy.  
Comparisons may be difficult because inconsistent definitions or classification systems are 
used, or data are not collected at all.  
Sources for identifying deaths  
 
Table 2 provides a brief overview of four main data-collection systems that can be used to 
identify and count maternal (or pregnancy-related), fetal, and neonatal deaths. In practice, all 
four have strengths, and as with most measurement systems, there are generally trade-offs 
between the reliability of the estimates, and practical considerations such as cost or time.  
 
Civil registration and vital statistics (CRVS) should capture all births and deaths (including 
cause-of-death information assigned by a medically-qualified person) in a country, on an 
ongoing basis, issuing certificates for these vital events. In ICD-10, WHO recommended a 
checkbox on the death certificate to record a woman’s pregnancy status at the time of death, 
enabling such systems to identify whether death was pregnancy-related.(30) Alternative 
systems have been used in China and India, where a “sample registration system”, (sample 
CRVS system) is in place for a number of population clusters which have been randomly 
selected from a national sampling frame.(31) In theory, the national scope and the ongoing 
effort makes CRVS the “gold standard” for measuring all deaths. Unfortunately, CRVS 
systems remain weak in most areas of highest mortality burden,(32-34) missing deaths and 
failing to cover certain areas. Moreover, cause-of-death ascertainment, needed to define 
maternal deaths, is frequently poor, and substantial proportions of maternal deaths are 
misclassified, even in high-income settings with complete CRVS.  The lack of CRVS is 
illustrated, for maternal mortality, in Figure 2. Fetal and early neonatal deaths, especially 
around viability are frequently under captured, with less than 5% globally having either a 
birth of death certificate.(35) 
 
Health Management Information Systems (HMIS) are a source of data on births and deaths 
that occur in health facilities. They usually fail to capture births and deaths which occur at 
home, and in many settings also exclude events in private-sector facilities. However, HMIS 
can be useful for monitoring trends within facilities, particularly for fetal and early neonatal 
outcomes, noting the limitation that facility use, and the case-mix of woman/babies using 
facilities, may change over time. Further limitations occur with neonatal or maternal deaths 
that happen after discharge. Deaths when a women is readmitted postpartum may not be 
recognised as pregnancy-related, and hence missed.  
 
Other alternatives include surveillance, through systems such as demographic surveillance 
sites or special studies like confidential enquiries. These may focus on deaths to women of 
reproductive age, and then retrospectively seek to ascertain whether the woman was 
pregnant or recently delivered at the time of death or may focus on deaths of pregnant or 
postpartum women.  Alternatively, they may adopt a cohort approach and seek to identify all 
pregnancies and the resulting outcome for both mother and her baby. These studies tend to 
operate at a sub-national level as they are resource-intensive. They may also be too small to 
provide precise estimates of maternal mortality unless aggregated over many years.  
 
Cross-sectional, population-based household surveys are an important source of data, 
particularly for neonatal mortality. A full livebirth or pregnancy history is typically used to 
identify births and neonatal deaths. Surveys using full pregnancy history are also potentially 
able to capture fetal deaths or stillbirths. Some surveys using a livebirth history have added 
a question regarding stillbirth, eg; the core DHS module, but for many surveys the capture of 
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stillbirths is implausibly low.(35, 36)  Measuring maternal mortality directly via surveys by 
asking household members about deaths of pregnant or recently delivered women within a 
given time period (often in the last one or two years) requires very large sample sizes(37) or 
a census(38).  Sisterhood method approaches ask siblings to report on the pregnancy-
related deaths of their sisters, and reduces the required sample size. However, they cannot 
capture of information on cause-of-death or on predictors associated with increased risk 
because it is unreasonable to expect a sibling to know and report such details.(39) 
 
Sources for ascertaining cause-of-death 
 
Information on the causes of maternal, fetal and neonatal deaths are important for identifying 
priority interventions to reduce mortality, and is a pre-requisite for defining maternal deaths, 
since the definition excludes causes that are incidental to pregnancy.   
 
Comparison of cause-of-death distributions between countries has been hampered by 
different classification systems, particularly for causes of stillbirths or fetal deaths.(40) To 
improve comparability, countries using ICD-10 should include all deaths coded to the 
maternal chapter (O codes) and maternal tetanus (A34) as maternal deaths, whilst all fetal 
and neonatal deaths should be coded to the perinatal chapter (P codes), congenital chapter 
(Q codes) or to a limited number of exceptions, including specific infections such as neonatal 
tetanus (A33) or congenital syphilis (A50).(8) In 2012, WHO published the ICD maternal 
mortality (ICD-MM) to be used in conjunction with the three ICD-10 volumes to reduce errors 
in coding maternal deaths, and to improve the attribution.(10) A similar manual to improve 
the coding of both stillbirths and neonatal deaths in ICD-10 is planned for release by WHO in 
2016. 
 
Ideally, detailed information on cause-of-death, distinguishing between immediate and 
underlying causes, should be possible to obtain from CRVS, with medical certification. 
Clinical diagnoses of causes can be supported with laboratory tests and even autopsies. 
WHO introduced a separate perinatal death certificate to obtain information on maternal and 
fetal conditions, but this has had limited uptake. However, population-based data on the 
causes of maternal, fetal and neonatal deaths are scarce in many high-burden countries, 
due to the lack of CRVS and medical certification.(33)  
 
Facility records can provide information on causes of death, but the extent to which these 
data represent causes of these deaths at the population level is questionable given low 
levels of institutional delivery across many parts of Asia and sub-Saharan Africa. For 
example, women delivering at home and experiencing post-partum haemorrhage may die 
very rapidly before reaching a facility for emergency care, potentially underestimating the 
proportion of deaths attributable to haemorrhage if only facility level data are used.  
 
Surveillance and surveys aiming to ascertain causes of maternal fetal and neonatal deaths 
in most high burden settings frequently rely on verbal autopsy (VA).(41, 42) In VA, family 
members or caregivers (lay reporters) of the deceased are asked about the signs and 
symptoms occurring before the death. Symptom data from VA interviews are then 
interpreted by physicians or by automated methods.(41, 43)  VA has some validity for 
causes of neonatal death in low-resources settings, however its performance is generally 
worse for fetal deaths.(44-47) VA performs better at identifying overall maternal deaths when 
compared to identifying direct causes of maternal death.(48) Overall, however, the imprecise 
nature of VA, and the potential for misclassification of cause-of-death at the individual level, 
means results from VA are usually presented at the population level rather for individual 
level diagnoses. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
Issues with establishing timing of death and survival status 
 
All of these sources rely on informants, be they health professionals with access to medical 
records or family members, and they are therefore subject to by some important limitations. 
Omission or misclassification of deaths can occur for several reasons. Firstly, where the 
information is not known by the informant (e.g. pregnancy status in a maternal death 
occurring in early pregnancy or in the post-partum period or gestational age at time of fetal 
death). Other examples include misclassification between intrapartum fetal death and early 
neonatal death which is thought to be common in low-resource settings, particularly when 
relying on VA.  
Secondly, omission or misclassification can occur where an informant deliberately withholds, 
or alters information. This can be motivated by desire to avoid stigma, for example families 
may not report pregnancy status in a young unmarried woman, termination of pregnancy, 
suicide or homicide. In facilities, healthcare workers may fear blame, and not report or 
misclassify deaths (e.g. record intrapartum stillbirths (potentially due to sub-standard care) 
as antepartum stillbirths (less incriminating for the birth attendant)).11,45 Furthermore, 
responses to VAs can be influenced by other factors including the sex of the interviewer.(49) 
It has been reported that women may be unwilling to report a fetal death to a male 
interviewer from her village.(36)  
 
Thirdly, accuracy and comparability can be hampered by inconsistent application of 
definitions, for example when fetal deaths are reported using variable definitions or for 
neonatal deaths where understanding the distribution of the day of death has been 
hampered by inconsistent use of day zero versus day one for the day of birth, and heaping 
of deaths on day seven (one week) affects the classification of early versus late neonatal 
deaths.(50) 
 
Potential solutions to identifying deaths, and defining them accurately and 
consistently 
 
We would argue that to ensure that all deaths are identified at a national level requires 
complete vital registration, ideally with proper medical certification of deaths, and a good 
classification system. ICD-11 is currently under development, along with a new single death 
certificate to include deaths at all ages, including stillbirths or fetal deaths.  This will record 
women’s pregnancy status and allow for the inclusion of both maternal and fetal/ neonatal 
contributing causes. Widespread uptake of this method of medical certification could improve 
our understanding of maternal, fetal and neonatal causes of death, and the links between 
them, and provide comparable estimates across different settings. Some settings link deaths 
of women to records of live-births or fetal deaths as a further way to identify possible 
maternal deaths.(51) Improving the classification of stillbirths and neonatal deaths and to 
increase comparability across settings will require a classification system with  a limited 
number of programmatically relevant, causal categories that can be assigned using VA, but 
can be further expanded in settings where detailed clinical data and diagnostics are 
available.(52) The new ICD perinatal mortality (ICD-PM) seeks to provide such a resource to 
improve coding of these deaths. It has been proposed for the 11th ICD revision to change to 
a gestational-age based stillbirth or fetal death threshold, in line with most high-income 
country reporting.   
 
For the many countries where complete vital registration is unlikely to become a reality for 
some years, if not decades, there are interim solutions. One solution to the challenge of 
capturing all maternal deaths, as is used in maternal death surveillance and response, is to 
first capture all deaths in women of reproductive age and then investigate the pregnancy 
status of the woman within 42 days of death, including with linkage to birth and fetal death 
records.(53) A potential solution for fetal and neonatal deaths is to investigate which survey-
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based methods (e.g. birth history, pregnancy history and truncated pregnancy history) best 
capture these deaths. Undoubtedly, e-health can form part of the solution in a number of 
ways, including more timely data collection through mobile devices (m-health) and through 
improved HMIS systems. 
  
Improving the ascertainment of the timing of deaths is clearly a major challenge, particularly 
between fetal and very early neonatal deaths, and better efforts are needed to redress 
drivers of misclassification. Improving gestational age assessment could include improving 
recall of last menstrual period, use of biomarkers, ultrasound assessment of gestational age 
after the first trimester and improved algorithms to enable a ‘best gestational age 
estimate’.(18, 54) Additionally, collecting information on the fetal heart beat on admission for 
all facility births could improve the categorisations of a death as either in the antepartum or 
intrapartum period. A positive, but unintended consequence of improved training in neonatal 
resuscitation may be improved recording of the distinction between intrapartum fetal, and 
early neonatal death.(55)  
 
Solutions are also needed to address sensitivities associated with reporting fetal, neonatal or 
maternal deaths. In facilities, fostering a no-blame culture of maternal and perinatal audit 
could have a role. Further investigation of methods to improve reporting in household 
surveys may focus on the interviewer, the informant, the role of stigma associated with these 
deaths, as well as the content of the questions.  
 
To accurately ascertain causes of death in pregnant and postpartum women, and their 
babies, clearly requires more precise methods. New simplified methods for collecting cause-
of-death data in resource poor settings are required, and investigations are currently 
underway to assess whether minimally invasive autopsies are feasible and acceptable.(56) 
Until other methods are available, we should strive to improve the quality of VAs and to 
understand the pitfalls of current methods of interpreting the data and the effects these may 
have on the estimated cause-specific mortality fractions. Estimates produced from VAs are 
likely to remain imprecise, and great caution should be applied when comparing cause-
specific mortality fractions over time or in different places, given that the extent to which 
imprecise tools provide correct estimates will vary depending on the sensitivity, specificity 
and the true percentage of deaths attributable to the cause in the population. 
 
Even with improved methods to diagnose causes of deaths, problems will still remain in how 
to distinguish deaths which should be classified as “maternal” (i.e. directly or indirectly 
related to pregnancy) from those assumed to be unrelated to the pregnancy. Recent 
evidence suggests it is not possible to distinguish indirect and coincidental HIV/AIDS-related 
deaths which calls into question the entire concept of maternal death as is currently 
defined.(57) Difficulties in identifying deaths aggravated by pregnancy have also been 
identified for other causes (e.g. malaria). We therefore agree with authors who argue that we 
should focus on measuring direct obstetric causes of deaths.(9) However, given that 
treatment provided to women within ANC/delivery services may prevent deaths which are 
not strictly related to the pregnancy – e.g. given that HIV-related deaths during pregnancy or 
the postpartum may be preventable with timely access to ART in the prenatal period – we 
believe it is also important, and relatively simple, to monitor all deaths to pregnant and 
postpartum women as well (i.e. pregnancy-related deaths). As such, we call on researchers 
to focus on measuring pregnancy-related mortality and, where possible, disaggregate these 
estimates by cause-of-death, ideally reporting cause-specific mortality ratios 
 
Using and interpreting mortality data 
 
Maternal, fetal and neonatal mortality data are used for numerous purposes including: 
examining the burden of mortality and trends in this over time; for identification of risk factors 
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for mortality and; for exploring effects of mortality on other outcomes (e.g. effect of a fetal 
death on maternal mental health, or effect of maternal death on infant survival). It can be 
useful to adopt a life course perspective on health problems, for example the effect of 
maternal health on long term outcomes for the newborn, or acute infections such as Zika 
virus. Mortality data can be used by a variety of end-users, from individual women and their 
families, to communities, front-line health providers, managers at a local or district level, 
national and global policy makers and researchers.  
 
Where possible, mortality data should be available by geographical area, rural or urban, 
place of death, timing, underlying cause (which can include both proximal biomedical 
causes, and wider social determinants and factors), and other disaggregations such as 
socio-economic status. This can help in identifying priorities, planning and monitoring 
progress and advocacy purposes. For example, understanding the timing of deaths in 
relation to pregnancy is programmatically useful. It has been repeatedly shown that the 
highest risk of pregnancy-related death occurs around delivery and in the immediate 
postpartum period;(58) but as direct obstetric causes of deaths decline and other causes of 
death including non-communicable disease become more important, this pattern may shift. 
This has programmatic implications, increasing the importance of providing care in the 
antenatal and postnatal period, and requiring linkages and integration of general health 
services beyond just those addressing obstetric causes. However, while such 
disaggregations are usually possible for neonatal and fetal mortality, for maternal mortality 
this is more challenging as it is a relatively rare outcome. At the facility level, for example, 
there are only likely to be one or two maternal deaths over a year.  
 
Cause-of-death data need to be interpreted with some caution. Changes in the percentage 
of deaths assigned to each cause can be driven by changes in one specific cause (see 
Figure 3). For example, as the percentage of deaths attributable to direct obstetric causes 
decrease with safe motherhood programmes we may see an increase in the proportion of 
deaths assigned to HIV/AIDs. This may either be due to an increase in HIV/AIDs-related 
deaths, or simply because the number of deaths attributable to HIV/AIDs is coming down at 
a slower pace than direct obstetric causes. In addition to proportions, therefore, the absolute 
numbers of each type of death should be related to the number at risk of dying (e.g. number 
of pregnant and postpartum women, number of births or the appropriate person years) to 
obtain absolute risks. This is particularly helpful for understanding how the risk of each 
cause-of-death is changing over time or between groups.  
 
In the next sections we present two very different uses of empirical data on maternal, 
neonatal and fetal mortality for: 1) producing global mathematical models and 2) audit.    
 
Estimating the mortality burden 
 
Attempts to quantify the global burden of maternal, fetal and neonatal mortality have been 
hampered by a lack of data. For maternal mortality, for example, only 52% of countries have 
any CRVS data since 2010 (with only 40% having high-quality CRVS data), while other 
countries must rely on modelled estimates (Figure 2). Three main groups have developed 
models to estimate the levels and trends of maternal and/ or neonatal mortality, the Institute 
for Health Metrics and Evaluation (IHME), the Maternal Mortality Estimation Inter-agency 
Group (MMEIG) and the UN Interagency Group for Child Mortality Estimation (UN-IGME). To 
date there have not been regular attempts to quantify the global burden of fetal deaths, 
although WHO has led two exercises to estimate fetal deaths.(3, 59) 
 
Whilst estimates can play an important role, especially to guide resource allocation and 
action in settings where high quality empirical data are not available, it is important to 
distinguish estimates from data and to recognize that not all estimates are equally 
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robust.(60) Some national estimates are derived from nationally representative data for 
those countries over multiple years, for example the UN-IGME estimates of overall neonatal 
mortality rates,(61) and therefore can be said to track mortality in each country. For other 
estimates, for example maternal mortality, stillbirth rate estimates and neonatal cause-of-
death, the estimates for many high burden countries are not based on data from that 
country, but from a model bringing together data from many countries, predicting the rates 
and changes in rates based on country-specific covariate values. Some countries contribute 
little or no input data to the modelling process. The resulting estimates do not track actual 
changes occurring, but provide predictions of what may be occurring in countries. One 
example of this is seen with respect to the drop in the percentage of maternal deaths 
attributable to HIV/AIDS from 9.0% in 2008 to 3.8% in 2013 in the MMEIG models and from 
32% in 2008 to 1.5% in 2013 in the IHME models.(62, 63) This is likely to principally reflect 
changes in the model assumptions. These changes to the models have been driven by not 
being able to accurately estimate which HIV-related deaths should be classified as indirect 
or coincidental to pregnancy, and will undoubtedly change as more evidence becomes 
available. The utility of results which are so sensitive to model assumptions is questionable, 
strengthening the case for focusing on improving measurement systems.(64)   
 
Audit 
 
Our inability to accurately measure levels and trends in mortality, as is the case in many high 
burden settings, contributes to the lack of an accountability mechanism in such countries, 
which in turn is likely to contribute to the lack of progress in reducing levels of maternal, fetal 
and neonatal mortality. To overcome this, audit is increasingly being used, particularly at the 
facility level, as a mechanism for surveillance and to identify avoidable factors leading to the 
death to improve quality of care. It requires a number of steps as follows:(53)  
 
1. Establish the objectives of the audit systems 
2. Identify maternal, neonatal or fetal deaths based on an appropriate case definition 
3. Collect data (facilities and/or communities) 
4. Investigate causes and circumstances of deaths 
5. Analysis and interpret the data 
6. Develop dissemination mechanism 
7. Respond 
8. Evaluate the audit system 
 
Such systems have been implemented across a range of settings for investigating maternal 
deaths including Malawi,(65) South Africa(66) and Nigeria,(67) though not without 
challenges. There is evidence that audits and feedback can lead to quality improvement,(68) 
and positive effects have been observed on maternal health services in settings where the 
audit system is underpinned by a national framework with properly implemented feedback 
mechanisms, leadership both from committed health professionals and the ministry of 
health, an enabling legal framework, and a workplace culture which promotes learning.(69, 
70)  
 
Despite the link between maternal, fetal and neonatal mortality, perinatal reviews have not 
been as widely adopted as maternal death reviews.(70, 71) A policy review found that of the 
51 “Countdown to 2015 for Maternal, Newborn and Child Health” priority countries which had 
a policy for maternal death notification, only 17 had a similar policy for perinatal death 
reviews in 2014.(70) Even in countries with a national policy on perinatal review, they are not 
necessarily implemented. For example, a qualitative study of maternal and perinatal death 
reviews in one region of Tanzania found that perinatal deaths are rarely reviewed.(72) There 
is, however, some limited evidence to suggest that reviewing fetal and neonatal deaths can 
lead to mortality reductions of round 30%, suggesting that audit could be an important tool 
for reducing the death of babies in high burden settings if it is effectively implemented.(73) 
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Conclusion 
 
Accurate and timely measurement is important to achieve change and end preventable 
maternal, neonatal and fetal mortality. However, as we have illustrated in this paper there 
are numerous obstacles to achieving this goal, particularly in high-burden settings. These 
challenges range from conceptual difficulties in the definitions of maternal and fetal mortality, 
to challenges faced in data collection systems making it impossible to count every birth and 
death, to problems of intentional or unintentional misclassification and inconsistent use of 
definitions or use of inconsistent classification systems or indicators.  
 
Equally there are many potential solutions, some of which we have presented in this paper. 
These might include expanded use of e-health platforms for data collection, and increased 
efforts to reduce the stigma around reporting a maternal, neonatal or fetal death. Certainly, 
we should consider how we can improve our definitions to enable comparable estimates, 
and limit the potential for misclassification. The close link between maternal, neonatal and 
fetal mortality – in, for example, timing and risks factors – means that many of the potential 
solutions will lead to improvement in measurements of all outcomes, and suggests the 
maternal and neonatal research communities need to collaborate to most efficiently improve 
measurement.    
Ultimately, however, solutions to measurement issues are only likely to be properly 
implemented if we have the political will to do so. This has become an even more 
challenging task in the era of the Sustainable Development Goals, where only one of 17 
goals is dedicated to health, and nested within this are sub-goals for reducing maternal and 
newborn mortality. In particular, it is critical that we improve visibility for tracking fetal deaths, 
in addition to maternal and neonatal ones.  
 
Practice Points 
Maternal, fetal and neonatal mortality data should be reported using standard definitions 
and, where possible, disaggregated by cause-of-death, ideally reporting cause-specific 
mortality ratios 
These mortality data can be used for numerous purposes including: examining the burden of 
mortality and trends in this over time; for identification of risk factors for mortality and; for 
exploring effects of mortality on other outcomes 
 
 
Research Agenda 
The close link between maternal, neonatal and fetal mortality – in, for example, timing and 
risks factors – means that many of the potential solutions will lead to improvement in 
measurements of all outcomes, and suggests the maternal and neonatal research 
communities need to collaborate to most efficiently improve measurement. 
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Tables and Figures 
 
Figures 
 
Figure 1: Schematic representation of times when maternal, fetal and neonatal deaths occur in 
relation to pregnancy. Adapted from Lawn et al, 2011(17)  
 
Figure 2: Empirically-measured data available for producing maternal mortality estimates 
(since 2010). Source: Produced using information from Alkema et al. 2015 & WHO, Trends in 
maternal mortality: 1990-2015 (available from: 
http://apps.who.int/iris/bitstream/10665/194254/1/9789241565141_eng.pdf?ua=1)  
Figure 3: Schematic showing four categories of ICD causes of neonatal death, shown as rates 
(bar) and percentages (pie) for the world, and two countries.  Comparing the pies for “pre-term 
birth” (in blue) suggests that deaths in this category are roughly the same world-wide, and in Country 
A and Country B. However the rates show that the preterm death rate is very low in Country A and 
very high in Country C.    
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
19 
 
 
 
 
Table 1: ICD-10 definitions of maternal, fetal and neonatal deaths(8) 
Indicator Primary threshold: Alternative threshold/ definition: 
Maternal death A death while pregnant or within 42 days of termination of 
pregnancy, irrespective of the duration & the site of the 
pregnancy, from any cause related to or aggravated by the 
pregnancy or its management but not from accidental or 
incidental causes.  
90 days (13) or 40 days(74) (13) 
Late maternal 
death 
A maternal death from direct or indirect obstetric causes, more 
than 42 days, but less than one year, after termination of 
pregnancy  
 
 
Pregnancy-related 
death 
A death while pregnant or within 42 days of termination of 
pregnancy, irrespective of the cause-of-death 
 
Early fetal death* A baby born with no signs of life with birthweight ≥500 -
<1000gms 
Gestational age ≥22 weeks or 
length ≥25cm (if birthweight not 
available) 
Late fetal death A baby born with no signs of life with birthweight ≥1000 gms Gestational age ≥28 weeks or 
length ≥35cm  (if birthweight not 
available) 
Intrapartum fetal 
death 
A fetal death occurring after the onset of labour, but before 
birth 
A baby born with no signs of life, 
but no evidence of skin maceration 
(Fresh stillbirth) is commonly used 
as surrogate marker(22) 
Antepartum fetal 
death 
A fetal death occurring prior to the onset of labour A baby born with no signs of life, 
with evidence of skin maceration 
(Macerated stillbirth) is commonly 
used as surrogate marker(22) 
Perinatal Death Composite indicator including all late fetal deaths and early 
neonatal deaths 
Other composite indicators for 
perinatal deaths are described in 
the text 
Early neonatal 
death 
A death of a liveborn baby at 0-6 days of age regardless of 
gestational age or birthweight 
 
Late neonatal 
death 
A death of a liveborn baby at 7 - 27 days of age regardless of 
gestational age or birthweight 
 
Neonatal death A death of a liveborn baby at 0 - 27 days of age regardless of 
gestational age or birthweight 
Deaths in the first month of life 
 
* Non-induced pregnancy losses with a birthweight <500g (or gestational age <22 weeks or length <25cm) are defined as 
miscarriages in ICD-10, although many countries (e.g. USA, Australia) report fetal deaths using a lower gestational age (≥20 
weeks definition) 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
20 
 
Table 2: Mechanisms for identifying maternal, fetal and neonatal deaths 
Mechanism Active vs passive 
data collection 
Frequency Notes 
Civil registration Passive Continuous Works well with high coverage, completeness of births and deaths 
registration, and with good ascertainment of cause-of-death. Can be 
easier to implement in urban areas. Low coverage in highest burden 
areas (Figure 2 for maternal). Sample vital registration approaches 
are taken in China and India  
Health Information 
Management Systems 
Passive Continuous Widespread in public-sector facilities in many countries. Quality 
variable, and data may not filter-up to aggregated levels. Frequently, 
low inclusion of private-sector. Platforms include District Health 
Information Systems 2 (www.dhis2.org/ )  
Surveillance  Predominantly 
Active  
Continuous 
or periodic 
Surveillance can be of whole populations, of pregnancies and their 
outcomes, or of deaths (either all deaths of reproductive aged 
females, or all pregnancy-related deaths. Can occur for short or 
prolonged periods (e.g. demographic surveillance sites). Surveillance 
can range from continuous case detection, to surveillance visits up to 
1 year apart. 
Population-based 
surveys (e.g. RHS, 
DHS and MICS) or 
Census 
Active Intermittent Surveys are the main source of mortality outcomes on the 45 million 
births occurring outside facilities. Fetal deaths are frequently omitted, 
and capture of fetal and early neonatal deaths may be of poor quality.  
Measuring maternal mortality based on reported household deaths 
via surveys requires very large sample sizes, or a census.  
Sisterhood method approaches reduce this requirement but limits the 
capture of information on cause-of-death or on co-variates (see main 
text for reasons).  
RHS=Reproductive Health Surveys (http://ghdx.healthdata.org/series/reproductive-health-survey-rhs) 
DHS=Demographic and Health Surveys (http://www.dhsprogram.com/) 
MICS=Multiple Indicator Cluster Surveys (http://mics.unicef.org/) 
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Figure 1: Schematic representation of times when maternal, fetal and neonatal deaths occur in relation to pregnancy. Adapted from Lawn et al, 
2011(17)  
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Figure 2: Empirically-measured data available for producing maternal mortality estimates (since 
2010). Source: Produced using information from Alkema et al. 2015 & WHO, Trends in maternal mortality: 
1990-2015 (available from: http://apps.who.int/iris/bitstream/10665/194254/1/9789241565141_eng.pdf?ua=1)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Schematic showing four categories of ICD causes of neonatal death, shown as 
rates (bar) and percentages (pie) for the world, and two countries.  Comparing the pies for 
“pre-term birth” (in blue) suggests that deaths in this category are roughly the same world-wide, 
and in Country A and Country B. However the rates show that the preterm death rate is very low 
in Country A and very high in Country C.    
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1. Levels and causes of mortality in mothers and babies are intrinsically linked 
2. Measuring levels, trends and causes of maternal, neonatal and fetal mortality are important 
for understanding priority areas for interventions and tracking their success  
3. There are standard definitions and indictors of measuring mortality in pregnant and 
postpartum women and their babies, presented in this paper 
4. Measurement challenges exist, awareness and attention to these would improve the 
measurement for these outcomes 
